{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "8454339",
  "DateCompleted": {
    "Year": "1993",
    "Month": "04",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "05",
    "Day": "26"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0019-9567",
      "JournalIssue": {
        "Volume": "61",
        "Issue": "4",
        "PubDate": {
          "Year": "1993",
          "Month": "Apr"
        }
      },
      "Title": "Infection and immunity",
      "ISOAbbreviation": "Infect Immun"
    },
    "ArticleTitle": "Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model.",
    "Pagination": {
      "StartPage": "1378",
      "EndPage": "1384",
      "MedlinePgn": "1378-84"
    },
    "Abstract": {
      "AbstractText": [
        "In this study, we developed a mouse model of skin infection to test the association between expression of immunoglobulin-binding proteins by and infectivity of group A streptococci. Group A streptococci capable of crossing tissue barriers and establishing a lethal systemic infection in mice showed a higher level of immunoglobulin-binding protein expression. The group A streptococci recovered from the spleen of a mouse that died following a skin infection were found to be more virulent when injected into the skin of naive mice. Together, these results suggest that immunoglobulin-binding protein expression by group A streptococci correlates with their ability to establish invasive skin infections."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology, Medical College of Ohio, Toledo 43699-0008."
          }
        ],
        "LastName": "Raeder",
        "ForeName": "R",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Boyle",
        "ForeName": "M D",
        "Initials": "MD"
      }
    ],
    "GrantList": [
      {
        "GrantID": "HL41898",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "S07-RR-05700",
        "Acronym": "RR",
        "Agency": "NCRR NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, U.S. Gov't, P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Infect Immun",
    "NlmUniqueID": "0246127",
    "ISSNLinking": "0019-9567"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Bacterial Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "IgG Fc-binding protein, Streptococcus"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Bacterial Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [
        "immunology",
        "microbiology"
      ],
      "DescriptorName": "Skin Diseases"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Streptococcal Infections"
    },
    {
      "QualifierName": [
        "immunology",
        "pathogenicity"
      ],
      "DescriptorName": "Streptococcus pyogenes"
    }
  ]
}